4
Changes in Ownership
Dolby Laboratories, Inc. Filed Acc 0001209191-21-007874
EVP & Chief Financial Officer sold 30,000 shares at $90.82 ($2,724,669)
- EVP & Chief Financial Officer acquired 30,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| CHEW LEWIS EVP & Chief Financial Officer | 2021-02-02 | Option exercise | +30,000 | $42.98 | $1,289,400 | 135,598 | D: show line 1 in the form |
| CHEW LEWIS EVP & Chief Financial Officer | 2021-02-02 | Sale | −30,000 | $90.82 | $2,724,669 | 105,598 | D: show line 2 in the form |
| Open-market sales · 30,000 sh · avg $90.82 · $2,724,669 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| CHEW LEWIS EVP & Chief Financial Officer | 2021-02-02 | Option exercise · Employee Stock Option (right to buy) | −30,000 | 60,918 | D: show line 3 in the form |
Loading xslF345X03/doc4.xml…